BioCentury
ARTICLE | Clinical News

MSL 109 human monoclonal antibody: The National Eye Institute began a Phase II/III trial in 325 patients that will measure time to progression as the primary en

October 2, 1995 7:00 AM UTC

Protein Design Labs Inc. (PDLI), Mountain View, Calif. Product: MSL 109 human monoclonal antibody Indication: Cytomegalovirus (CMV) retinitis in AIDS Status: The National Eye Institute began a Phase I...